Hospital groups want to intervene in opposition to three more drug manufacturers' lawsuits against the federal government over 340B contract pharmacy requirements.

Hospitals Want Role in Three More Pharma Lawsuits Over 340B Contract Pharmacy

In Federal, JudicialMarch 4, 202140 Views

Tom Mirga

Hospital groups that recently filed a motion to intervene in opposition to drug manufacturer Eli Lilly’s lawsuit against the federal government over 340B contract pharmacy requirements also are trying to intervene in similar suits against the government by manufacturers AstraZeneca, Novo Nordisk, and Sanofi.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Exact matches only

Search in title

Search in content

Search in excerpt

Hidden

*Sign up for news summaries and alerts from 340B Report